Journal article
Everolimus, when combined with exemestane, adds toxicity with minimal benefit for women with breast cancer
Authors
Tannock IF; Pond GR
Journal
Annals of Oncology, Vol. 25, No. 10,
Publisher
Elsevier
Publication Date
October 1, 2014
DOI
10.1093/annonc/mdu371
ISSN
0923-7534